Research News for 2010
-
Centers for Disease Control Creates New Committee to Help Young Women Learn More About Breast Health
The CDC has created a new committee to help younger women, especially women younger than 40 and women at high risk of breast cancer, learn more about breast health and breast cancer.
-
Experimental Eribulin May Help Treat Various Types of Metastatic Breast Cancer
Research suggests that the experimental medicine eribulin may be a good treatment for various types of metastatic breast cancer that have stopped responding or failed to respond to other treatments.
-
Herceptin Works Well in Older Women Diagnosed with HER2-Positive, Metastatic Disease
A small study suggests that older women diagnosed with HER2-positive, metastatic breast cancer can benefit from Herceptin treatment.
-
Experimental Iniparib Plus Chemo Can Help Treat Metastatic, Triple-Negative Disease
A small study found that iniparib -- one of several new, experimental medicines called PARP inhibitors -- improved survival when combined with chemotherapy to treat metastatic, triple-negative breast cancer.
-
Herceptin Effectiveness Not Affected by Obesity
A small study found that Herceptin worked equally well in obese and non-obese women diagnosed with HER2-positive, metastatic breast cancer.
-
Experimental T-DM1 May Help Treat Metastatic, HER2-Positive Disease
A small, early study suggests that T-DM1, an experimental medicine, may be a better first treatment for women diagnosed with metastatic, HER2-positive breast cancer than a combination of Herceptin and Taxotere.
-
Research Says Lymphedema Risk Is Ongoing
New research suggests that lymphedema may be more common and last longer than generally thought.
-
Use of Computer-Aided Detection to Read Mammograms Up
Research shows that computer-aided detection (CAD) is used in most mammograms paid for by Medicare.
-
Chemotherapy Before Surgery Can Benefit Advanced-Stage, Triple-Negative Breast Cancer
A small, early study found that 66% of locally-advanced, triple-negative breast cancers treated before surgery with a combination of carboplatin and Taxotere had no living cancer cells in the tumor when it was removed.
-
Arimidex-Testosterone Combo May Ease Menopausal Symptoms
An experimental testosterone/Arimidex pellet implanted under the skin every 90 days may help ease menopausal symptoms in breast cancer survivors.
